STOCK TITAN

Director Itzhaik Asaf details restricted share holdings at Polyrizon (PLRZ)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Polyrizon Ltd. director Itzhaik Asaf filed an initial statement of beneficial ownership, detailing restricted ordinary share holdings. One grant covers 2 restricted ordinary shares that vest in 7 equal quarterly installments beginning on April 30, 2026, subject to continued service.

A second grant covers 3,646 ordinary shares, of which 521 are already vested and 3,125 restricted ordinary shares vest in 6 equal quarterly installments beginning on March 31, 2026, also contingent on continued service. Certain securities are held in the name of a trustee to qualify for tax benefits under Section 102 of the Israeli Tax Ordinance.

Positive

  • None.

Negative

  • None.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Itzhaik Asaf

(Last)(First)(Middle)
C/O POLYRIZON LTD.
9 HAPNINA STREET

(Street)
RAANANA4321546

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026
3. Issuer Name and Ticker or Trading Symbol
Polyrizon Ltd. [ PLRZ ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares2(1)(3)D
Ordinary Shares3,646(2)(3)D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. These ordinary shares represent restricted ordinary shares, which vest in 7 equal quarterly installments on a quarterly basis beginning on April 30, 2026, subject to the Reporting Person's continued service.
2. These ordinary shares represent restricted ordinary shares, of which (1) 521 ordinary shares are vested and (2) 3,125 restricted ordinary shares vest in 6 equal quarterly installments on a quarterly basis beginning on March 31, 2026, subject to the Reporting Person's continued service.
3. To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Polyrizon Ltd. Amended and Restated Equity Incentive Plan must be registered in the name of a trustee.
/s/ Asaf Itzhaik03/18/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Polyrizon (PLRZ) Form 3 filing by Itzhaik Asaf show?

The Form 3 shows initial beneficial ownership for director Itzhaik Asaf in Polyrizon ordinary shares, including restricted share grants with specific quarterly vesting schedules and existing vested shares, all subject to his continued service with the company.

How many Polyrizon (PLRZ) shares in the Form 3 are currently vested?

The filing states that 521 ordinary shares are vested from one restricted share grant. The remaining restricted shares in that grant, along with another small restricted grant, vest over future quarterly installments, subject to continued service conditions.

What are the vesting terms of Itzhaik Asaf’s restricted shares in Polyrizon (PLRZ)?

One grant of 2 restricted ordinary shares vests in 7 equal quarterly installments starting April 30, 2026. Another grant has 3,125 restricted ordinary shares vesting in 6 equal quarterly installments starting March 31, 2026, both requiring continued service.

Does the Polyrizon (PLRZ) Form 3 indicate any insider buying or selling?

The Form 3 does not report buy or sell transactions. It is an initial ownership statement listing existing ordinary and restricted ordinary share positions and their vesting schedules, rather than recording new market purchases or sales.

Why are some Polyrizon (PLRZ) shares held by a trustee under Section 102?

The filing notes that to receive tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued under the Polyrizon Amended and Restated Equity Incentive Plan must be registered in the name of a trustee for the employee’s benefit.

What role does Itzhaik Asaf hold at Polyrizon (PLRZ) in this Form 3?

The Form 3 identifies Itzhaik Asaf as a director of Polyrizon Ltd. The reported share and restricted share holdings reflect his equity-based compensation and ownership position associated with this board role.
Polyrizon Ltd

NASDAQ:PLRZ

View PLRZ Stock Overview

PLRZ Rankings

PLRZ Latest News

PLRZ Latest SEC Filings

PLRZ Stock Data

14.06M
1.43M
Biotechnology
Healthcare
Link
Israel
Ra'anana